Show
Sort by
-
Is postoperative FEV1 (poFEV1) more accurately estimated by functional respiratory imaging (FRI) than by conventional methods?
-
Screening tools for a high risk population: can we screen for early mesothelioma?
-
Volatile organic compounds as diagnostic tool for malignant pleural mesothelioma
-
Quantification of radiation-induced lung damage with CT scans: the possible benefit for radiogenomics
-
Proton radiotherapy for locally-advanced non-small cell lung cancer, a cost-effective alternative to photon radiotherapy in Belgium?
-
Second opinion for thoracic cancer and its impact on diagnosis and treatment strategy: a single institutional series
-
Resistance training in patients with radically treated respiratory cancer: mature results of a multi-centre randomised phase 3 trial (REINFORCE)
-
Initial analysis of the International Association For the Study of Lung Cancer Mesothelioma database
-
Phase II clinical trial of first or second-line treatment with bortezomib in patients with malignant pleural mesothelioma
-
Activating EGFR mutations in patients with non small cell lung cancer: prevalence and predictors in a caucasian series